Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ulcerative Colitis, Active”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07136116
What this trial is testing

Study to Assess Change in Disease Activity of Risankizumab Treatment in Japanese Participants With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AbbVie 200
Large-scale testing (Phase 3)Looking for participantsNCT06588855
What this trial is testing

Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Moderately to Severely Active Ulcerative Colitis
Hoffmann-La Roche 350
Early research (Phase 1)Study completedNCT01759056
What this trial is testing

Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Avaxia Biologics, Incorporated 33
Testing effectiveness (Phase 2)Ended earlyNCT02808390
What this trial is testing

Efficacy and Safety Study of GED-0507-34-Levo for Treatment of UC

Who this might be right for
Ulcerative Colitis
PPM Services S.A. 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT06254950
What this trial is testing

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Takeda 213
Testing effectiveness (Phase 2)Study completedNCT06398808
What this trial is testing

Evaluate the Efficacy and Safety of ZYIL1 Oral Capsules for the Treatment of Patients With Mild to Moderately Active Ulcerative Colitis Resistant or Intolerant to Oral Aminosalicylates

Who this might be right for
Ulcerative Colitis
Zydus Lifesciences Limited 24
Testing effectiveness (Phase 2)Ended earlyNCT02764229
What this trial is testing

Open-label Extension Study to Assess Safety and Tolerability of LYC-30937-EC in Subjects With Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Lycera Corp. 112
Not applicableLooking for participantsNCT06838845
What this trial is testing

An Observational Study to Evaluate Effectiveness and Safety of Upadacitinib in Chinese Adult Participants With Moderate to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
AbbVie 80
Post-approval studies (Phase 4)Study completedNCT04259138
What this trial is testing

Determination of the Optimal Treatment Target in Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Alimentiv Inc. 672
Not applicableLooking for participantsNCT06895252
What this trial is testing

Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
All India Institute of Medical Sciences 220
Post-approval studies (Phase 4)Looking for participantsNCT06095128
What this trial is testing

Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
Takeda 60
Not applicableStudy completedNCT01289366
What this trial is testing

Endocytoscopy for in Vivo Determination of Mucosal Inflammatory Cells and Intestinal Disease Activity in Inflammatory Bowel Disease (IBD)

Who this might be right for
Crohn´s DiseaseUlcerative Colitis
University of Erlangen-Nürnberg Medical School 40
Large-scale testing (Phase 3)Study completedNCT03996369
What this trial is testing

Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Arena Pharmaceuticals 354
Testing effectiveness (Phase 2)Study completedNCT02647866
What this trial is testing

Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis

Who this might be right for
Ulcerative ColitisDigestive System DiseasesColitis, Ulcerative+7 more
Kyowa Kirin, Inc. 66
Not applicableEnded earlyNCT00837304
What this trial is testing

Colon Capsule Endoscopy Versus Standard Colonoscopy in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
University Hospital Muenster 14
Testing effectiveness (Phase 2)Looking for participantsNCT07415044
What this trial is testing

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)Ulcerative Colitis, Active ModerateUlcerative Colitis, Active Severe
Eli Lilly and Company 1,431
Testing effectiveness (Phase 2)Looking for participantsNCT07083193
What this trial is testing

AC-101 Tablets in Participants With Moderate to Severe Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Accro Bioscience (Suzhou) Limited 24
Testing effectiveness (Phase 2)Ended earlyNCT03269695
What this trial is testing

Efficacy, Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission.

Who this might be right for
Ulcerative Colitis
Pfizer 20
Not applicableStudy completedNCT01534312
What this trial is testing

Casein Glycomacropeptide in Active Distal Ulcerative Colitis (Pilot Study)

Who this might be right for
Colitis, UlcerativeInflammatory Bowel Diseases
University of Aarhus 24
Large-scale testing (Phase 3)Active Not RecruitingNCT03221036
What this trial is testing

Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative Colitis

Who this might be right for
Moderately to Severely Active Ulcerative Colitis
Takeda 392
Next Page